We initially sought to develop a ctDNA assay that would be widely applicable for monitoring STS patients, by screening the three most commonly mutated genes in STSs (TP53, RB1 and ATRX; www.cbioportal.org). The gene discussed is TP53; the disease is telomere syndrome.